Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in demand for Stemcell treatment
4.1.2 Rise in diseased population
4.1.3 Advancement in research on human tissues
4.2 Restraints
4.2.1 Complications in Stemcell treatment
4.2.2 High-cost procedure
4.3 Opportunities
4.3.1. Research in pharmaceutical and biotechnology
4.4 Challenges
4.4.1. To reduce contamination and cancer risk
Chapter 5 Europe Stemcell Therapeutics Market- By Treatment
5.1 Syngeneic Stem Cell Therapy
5.1.1 Neurology
5.1.2 Cardiology
5.1.3 Oncology
5.1.4 Diabetes
5.1.5 Hematology
5.2 Allogeneic Stem Cell Therapy
5.3 Autologous Stem Cell Therapy
Chapter 6 Europe Stemcell Therapeutics Market- By Geography
6.1 Introduction
6.2 Europe
6.2.1 Germany
6.2.2 Spain
6.2.3 UK
6.2.4 France
6.2.5 Russia
6.2.6 Italy
Chapter 7 Europe Stemcell Therapeutics Market- Company Profiles
7.1 Kite Pharma
7.2 Invitrogen
7.3 Cytori Therapeutics, Inc.
7.4 Cellular Engineering Technologies Inc.
7.5 Geron Corporation
7.6 Neuralstem, Inc.
7.7 Advanced Cell Technology
7.8 Athersys
7.9 Stemcells, Inc.
7.10 Aastrom Biosciences, Inc.
7.11 CellGenix GmbH
7.12 Takara Bio USA Holdings, Inc.
7.13 Osiris Therapeutics, Inc.
7.14 NsGene
7.15 Novocell
Chapter 8 Europe Stemcell Therapeutics Market- Competitive Landscape
8.1. Market Share Analysis
8.2. Strategies Adopted by top companies
8.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 9 Market Insights
9.1. Industry Experts Insights
9.2. Analysts Opinions
9.3. Investment Opportunities
Chapter 10 Appendix
10.1 List of Tables
10.2 List of Figures
